INmune Bio to announce top line Phase 2 MINDFuL Alzheimer's data on June 30

Inmune Bio, Inc.

Conference call scheduled for June 30, 2025 at 8:00 AM ET to present top line Phase 2 MINDFuL results.
MINDFuL trial is a Phase 2 study in early Alzheimer's disease.
Press release issued June 26, 2025 announcing the upcoming data call.
Dial-in: +1-800-267-6316 (US) or +1-203-518-9783 (international), Conference ID: INMUNE.
Replay available through July 30, 2025.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.